Persistence Pays Off for Patient with Lung Cancer
In December 2023, a space opened in a clinical trial at Dana-Farber of a novel targeted drug. Rosemary Conway, 68, who had stage IV lung cancer, was eager to fill it. She had been waiting nearly six years for a trial of a medicine that would target a specific genetic mutation driving the growth of … Read more